世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の子宮内避妊具(IUD)市場 2019-2023年

Global Intrauterine Contraceptive Devices (IUD) Market 2019-2023

IRTNTR30714

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2019年1月US$2,500
シングルユーザライセンス
123

サマリー

この調査レポートは世界の子宮内避妊具(IUD)市場を分析・予測したTechNavioの市場調査報告書です。

Description

About this market
Effective contraception and reduced side effects of IUDs boost the growth of the global intrauterine contraceptive devices market. The popularity of IUDs is gaining momentum globally owing to their safety, efficacy, long-term use, and reduced risk burden. Once inserted, the devices require no additional actions on the part of the user. In the context of safety, the IUD is not only an appropriate choice but should also be considered as the first-line of contraception for adolescents and nulliparous women. The risk of PID with the use of IUDs is not higher than in the general population, and the initial risk is observed only within the first twenty days after IUD insertion. For women, the benefits of the IUD often outweigh the minor risks. IUDs can be used even after miscarriage, abortion, or childbirth. Copper IUDs do not contain hormones, and hence, can be used by breastfeeding mothers. These devices can be used as contraception even in emergencies. Technavio’s analysts have predicted that the intrauterine contraceptive devices (IUD) market will register a CAGR of almost 4% by 2023.
Market Overview
Increasing initiatives by government and non- profit organizations
In the initial years of promotion on family planning, governments had to emphasize their efforts on more than one contraceptive method. As one of the methods became established and popular, it was desired by people. The imprints of early priority policies are well visible in countries displaying the high use of IUD, such as Vietnam, China, and several countries of the former Soviet Union.
Adverse effects of IUDs
IUDs are safer and more effective and must be approved by the FDA for market launch. Nevertheless, as with any medical device, IUDs have certain adverse effects. Menorrhagia, dysmenorrhea, and polymenorrhea have been the major reasons for the discontinuation of IUDs by users. However, serious issues with the use of IUDs are uncommon. Such adverse effects with the use of IUDs can make individuals opt for other contraceptive methods.
For the detailed list of factors that will drive and challenge the growth of the intrauterine contraceptive devices (IUD) market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fairly fragmented and with the presence of several companies. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.



目次

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY TYPE
- Market segmentation by type
- Comparison by type
- Hormonal intrauterine device - Market size and forecast 2018-2023
- Copper intrauterine device - Market size and forecast 2018-2023
- Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USER
- Market segmentation by end-user
- Comparison by end-user
- Hospitals - Market size and forecast 2018-2023
- Gynecology clinics - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by end-user
PART 09: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Europe - Market size and forecast 2018-2023
- North America - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- ALLERGAN
- Bayer
- EUROGINE
- Mylan
- Pregna
- The Cooper Companies
PART 15: APPENDIX
- Research methodology
- List of abbreviations
PART 16: EXPLORE TECHNAVIO

Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Type - Market share 2018-2023 (%)
Exhibit 18: Comparison by type
Exhibit 19: Hormonal intrauterine device - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Hormonal intrauterine device - Year-over-year growth 2019-2023 (%)
Exhibit 21: Copper intrauterine device - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Copper intrauterine device - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by type
Exhibit 24: Customer landscape
Exhibit 25: End-user - Market share 2018-2023 (%)
Exhibit 26: Comparison by end-user
Exhibit 27: Hospitals - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Hospitals - Year-over-year growth 2019-2023 (%)
Exhibit 29: Gynecology clinics - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Gynecology clinics - Year-over-year growth 2019-2023 (%)
Exhibit 31: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Others - Year-over-year growth 2019-2023 (%)
Exhibit 33: Market opportunity by end-user
Exhibit 34: Market share by geography 2018-2023 (%)
Exhibit 35: Geographic comparison
Exhibit 36: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 38: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: North America - Year-over-year growth 2019-2023 (%)
Exhibit 40: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 41: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 42: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 43: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 44: Key leading countries
Exhibit 45: Market opportunity
Exhibit 46: Impact of drivers and challenges
Exhibit 47: IUD types
Exhibit 48: Vendor landscape
Exhibit 49: Landscape disruption
Exhibit 50: Vendors covered
Exhibit 51: Vendor classification
Exhibit 52: Market positioning of vendors
Exhibit 53: ALLERGAN - Vendor overview
Exhibit 54: ALLERGAN - Business segments
Exhibit 55: ALLERGAN - Organizational developments
Exhibit 56: ALLERGAN - Segment focus
Exhibit 57: ALLERGAN - Key offerings 0
Exhibit 58: Bayer - Vendor overview 1
Exhibit 59: Bayer - Product segments 1
Exhibit 60: Bayer - Organizational developments 2
Exhibit 61: Bayer - Geographic focus 3
Exhibit 62: Bayer - Segment focus 3
Exhibit 63: Bayer - Key offerings 3
Exhibit 64: EUROGINE - Vendor overview 5
Exhibit 65: EUROGINE - Key offerings 5
Exhibit 66: Mylan - Vendor overview 7
Exhibit 67: Mylan - Business segments 7
Exhibit 68: Mylan - Organizational developments 8
Exhibit 69: Mylan - Segment focus 8
Exhibit 70: Mylan - Key offerings
Exhibit 71: Pregna - Vendor overview
Exhibit 72: Pregna - Key offerings
Exhibit 73: The Cooper Companies - Vendor overview
Exhibit 74: The Cooper Companies - Business segments
Exhibit 75: The Cooper Companies - Organizational developments
Exhibit 76: The Cooper Companies - Geographic focus
Exhibit 77: The Cooper Companies - Segment focus
Exhibit 78: The Cooper Companies - Key offerings

?

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る